Skip to content


Editors' Profile

RL Coleman

Dr Robert L Coleman, Editor-in-Chief

Robert L. Coleman, MD is the Ann Rife Cox Professor in Gynecology & Deputy Chair in the Department of Gynecologic Oncology & Reproductive Medicine at The University of Texas MD Anderson Cancer Center, where he also serves as Vice-Chair, Clinical Research. Dr Coleman’s research interests include novel therapeutics for gynecologic cancers, clinical trial development and statistical design. He serves on the NRG’s Ovarian and Developmental Therapeutics Committees, and is PI or co-PI for several prospective clinical trials. He currently is a co-project leader for the MDACC Ovarian SPORE, the MDACC Uterine SPORE, the Ovarian Cancer Research Fund, and CPRIT, each of which is sponsoring novel therapeutics trials in gynecologic cancers. Dr Coleman has authored or coauthored over 400 scientific publications, including over 180 peer-reviewed original research articles, numerous book chapters, monographs, invited articles and textbooks. Dr Coleman is President-Elect for the Society of Gynecologic Oncology, Secretary Treasurer for the International Gynecologic Cancer Society, and serves on the American Board of Obstetrics and Gynecology, Division of Gynecologic Oncology.

T Herzog

Dr Thomas Herzog, Editor-in-Chief

Dr Thomas Herzog is the Director of Gynecologic Oncology and the Physicians & Surgeons Endowed Professor of Clinical Gynecology and Obstetrics.  He is also the Clinical Director of the University of Cincinnati Cancer Institute. Previously, he was the Fellowship Director in Gynecologic Oncology for Columbia & Cornell. He has served as a Principal Investigator in a number of GOG trials with a special emphasis in ovarian and endometrial cancers. Dr Herzog has authored/co-authored over 225 peer-reviewed articles and lectures extensively. Dr Herzog has been on the leadership council of the Society of Gynecologic Oncology, the Foundation for Women´s Cancer, Board of Governors for the American College of Surgeons. In 2013, he was elected to the Board of the American Board of Obstetrics and Gynecology.

B Monk

Dr Bradley J Monk, Editor-in-Chief

Dr Monk is currently Professor and Director in the Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Creighton University School of Medicine at St. Joseph´s Hospital and Medical Center in Phoenix, AZ. Dr Monk is also a Professor on the Clinical Scholar Track at the University of Arizona College of Medicine – Phoenix. Dr Monk´s research interests include chemotherapy to treat ovarian and cervical carcinoma; the etiology, biomarkers in gynecologic cancers; and quality of life in women with advanced ovarian cancer. He is on the Board of Directors for the Gynecologic Oncology Group (GOG) and is the Group´s Cervical and Vulvar Committee Chair. Dr Monk has authored more than 180 peer-reviewed articles along with 27 book chapters.

Annual Journal Metrics

  • Speed
    57 days to first decision for reviewed manuscripts only
    59 days to first decision for all manuscripts
    121 days from submission to acceptance
    17 days from acceptance to publication

    12 Altmetric Mentions